CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net earnings	$ 287,126	$ 234,623
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	80,844	86,836
Loss on sale/disposal of long-lived assets	51	157
Deferred income taxes	(12,969)	(6,392)
Share-based compensation	15,164	13,213
Non-cash restructuring charges	3,049	0
Change in operating assets and liabilities, net of businesses acquired and divested:
Accounts receivable, net	(120,795)	(56,195)
Inventories, net	(71,683)	(56,632)
Accounts payable and accrued expenses	(15,206)	(42,020)
Deferred revenue	85,579	37,598
Net pension and postretirement liabilities	(13,218)	(14,128)
Other current and long-term assets and liabilities	5,034	(31,343)
Net cash provided by operating activities	242,976	165,717
Cash flows from investing activities:
Proceeds from sale/disposal of long-lived assets	1,206	464
Additions to property, plant, and equipment	(37,703)	(32,037)
Acquisition of business, net of cash acquired	(33,756)	0
Net cash used for investing activities	(70,253)	(31,573)
Cash flows from financing activities:
Borrowings under revolving credit facility	16,615	586,230
Payments of revolving credit facilities	(16,615)	(586,230)
Principal payments on debt	0	(202,500)
Repurchases of common stock	(137,580)	(37,366)
Proceeds from share-based compensation	11,345	10,583
Dividends paid	(15,707)	(14,950)
Proceeds from (Payments for) Other Financing Activities	(876)	(813)
Net cash used for financing activities	(142,818)	(245,046)
Effect of exchange-rate changes on cash	7,078	2,737
Net increase (decrease) in cash and cash equivalents	36,983	(108,165)
Cash and cash equivalents at beginning of period	406,867	256,974
Cash and cash equivalents at end of period	$ 443,850	$ 148,809